Regeneron Says CHMP Recommends Conditional Marketing Authorization For Odronextamab In EU

RTTNews | 125 dagar sedan
Stocktwits
Regeneron Says CHMP Recommends Conditional Marketing Authorization For Odronextamab In EU

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional marketing authorization of odronextamab to treat adults with relapsed/refractory (R/R) follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma (DLBCL), after two or more lines of systemic therapy.

The European Commission is expected to announce a final decision in the coming months. FL and DLBCL are the two most common subtypes of B-cell non-Hodgkin lymphoma (B-NHL).

The positive CHMP opinion is supported by results from the Phase 1 ELM-1 and pivotal Phase 2 ELM-2 trials, which demonstrated robust, durable response rates and an acceptable safety profile of odronextamab in adults with R/R FL or R/R DLBCL. The EMA previously granted odronextamab Orphan Designation for both FL and DLBCL. Odronextamab is currently under clinical development and has not been approved by any regulatory authority.

Regeneron continues to evaluate the use of odronextamab as a monotherapy and in combination across earlier lines of therapy in challenging-to-treat lymphomas.

Taggar: REGN
Stocktwits
read more
Regeneron Pharma Q2 Results Top Estimates - Update

Regeneron Pharma Q2 Results Top Estimates - Update

Biotechnology company Regeneron Pharmaceuticals, Inc. (REGN) reported on Thursday that net income for the second quarter increased to $1.43 billion or $12.41 per share from $968 million or $8.50 per share in the prior-year quarter.
RTTNews | 91 dagar sedan
Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharmaceuticals, Inc. (REGN) reported on Friday that net income for the fourth quarter declined 3 percent to $1.16 billion or $10.19 per share from $1.20 billion or $10.50 per share in the prior-year quarter.
RTTNews | 272 dagar sedan
Regeneron Completes Acquiring Sanofi's Stake In Libtayo

Regeneron Completes Acquiring Sanofi's Stake In Libtayo

Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that it has completed the acquisition of French drug major Sanofi's (SNYNF, SNY) stake in Libtayo (cemiplimab), providing Regeneron with exclusive worldwide development, commercialization, and manufacturing rights to the medicine originally discovered in Regeneron's laboratories. The intent to purchase Libtayo was announced on June 2, 2022.
RTTNews | 853 dagar sedan
Dollar Turns In Mixed Performance Ahead Of Jobs Data

Dollar Turns In Mixed Performance Ahead Of Jobs Data

The U.S. dollar recovered from early losses on Thursday after fairly encouraging economic data dashed hopes of any aggressive interest rate cut by the Federal Reserve next week, but gave up gains as the day progressed with investors awaiting non-farm payroll data due on Friday, and the presidential election next week.
RTTNews | 4h 52minuter sedan
Canadian Market Headed For Weak Close

Canadian Market Headed For Weak Close

Disappointing earnings updates from U.S. tech majors Microsoft Inc., and Meta Platforms, anxiety ahead of U.S. presidential election and the Federal Reserve's monetary policy meeting, and weak commodity prices are weighing on the Canadian market.
RTTNews | 6h 53minuter sedan
Swiss Market Ends Weak Again

Swiss Market Ends Weak Again

For the second consecutive day, the Switzerland market languished in red right through the day's session, as weak earnings updates from U.S. technology majors Microsoft Inc., and Meta Platforms, and weak euro zone inflation data hurt sentiment and sent stock prices drifting down south on Thursday.
RTTNews | 7h 43minuter sedan
Pound Falls After Autumn Statement

Pound Falls After Autumn Statement

The pound weakened against its major counterparts in the New York session on Thursday, following the announcement of the nation's latest budget, which included tax rises and big spending plans.
RTTNews | 7h 44minuter sedan
Verktyg
Ekonomisk kalender
Market Hours
Interest Rates
Holidays Calendar
Forex Marknad
Forex Volatilitet
Forex Korrelation
Forex Nyheter
forex analysis
COT Data
Likviditet
Forex Kalkylatorer
Forex värmekarta
Indicators Heatmap
Gemenskapen
Gemenskapen
Systems
De mest populära systemen
Strategier
Tävlingar
Forex Diagram
Forex Sentiment
Indikator för utsikter
Recensioner
Mäklare
Prop Trading Firms
VPS-tjänster
Signalleverantörer
EA-programmeringstjänster
Affiliate Programs
PAMM mäklartjänster
Tjänster för rabattprogram
Trading Plattformar
Expertrådgivare
krypto Börser
Trading Courses
Mäklare
Forex Sprider sig
Forex Citat från mäklare
Forex mäklare Swaps
Forex Volym för mäklare
Forex Kampanjer för mäklare Broker News
Plattform
Widgetar
Funktioner
API
RSS
Stock Portfolio
Affiliate Software
Avancerade diagram
Stöd
FAQ
Hjälp
Kontakta oss
Rapportera en bugg!
Om
Blogg
© 2024 Myfxbook Ltd. Alla rättigheter reserverade
HIGH RISK WARNING: Valutahandel innebär en hög risknivå som kanske inte är lämplig för alla investerare. Hävstångseffekten skapar ytterligare risker och förlustexponering. Innan du bestämmer dig för att handla med utländsk valuta bör du noga överväga dina investeringsmål, din erfarenhetsnivå och din risktolerans. Du kan förlora en del av eller hela din ursprungliga investering. Investera inte pengar som du inte har råd att förlora. Utbilda dig om de risker som är förknippade med valutahandel och sök råd från en oberoende finansiell eller skatterådgivare om du har några frågor. Alla uppgifter och all information tillhandahålls endast i informationssyfte och är inte avsedda för handelsändamål eller rådgivning. Tidigare resultat är inte en indikation på framtida resultat.